In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $49.49, denoting a -0.2% change from the preceding trading day.

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $49.59, marking a -0.56% move from the previous day.

CRISPR Therapeutics' stock may seem boring due to slow FDA trial and rollout process, but it's a strong long-term investment.

Nairobi Governor Johson Sakaja has announced that 113,000 youth applied for the Climate Resilience Service Program (CRSP) ...

President William Ruto has officially launched the Climate Resilience Service Program (CRSP) which is set to provide over 200, 000 job opportunities for the Kenyan youth. The President launched the ...

BMO Capital Markets managing director of biopharma equity research Evan Seigerman joins Market Domination to discuss the best ...

In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against the other ARK stocks. Investing comes in all sizes and flavors. For the risk averse ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Crispr Therapeutics 40% share in Casgevy could result in revenue annual between $1.2 billion and $2.8 billion towards the end ...

Despite gaining regulatory approvals in many countries for the first ever CRISPR-based gene therapy, investors should remain wary of investing in CRISPR Therapeutics' (CRSP) early-stage pipeline. Gene ...

The study finds that investors are selling and repurchasing nearly identical exchange-traded funds (ETFs), a group of stocks, ...